Abstract
Neural membranes are composed of phospholipids, sphingolipids, cholesterol, and proteins. The distribution of lipids in two leaflets of lipid bilayer is asymmetric (Ikeda et al., 2006; Yamaji-Hasegawa and Tsujimoto, 2006). Asymmetric distribution of lipids is needed for structural integrity necessary for protein function. Sphingolipids and cholesterol interact with each other via hydrogen bonds, hydrophobic forces, and van der Waal interactions (Simons and Ikonen, 1997).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adibhatla R. M., Hatcher J. F., and Dempsey R. J. (2006). Lipids and lipidomics in brain injury and diseases. AAPS J. 8:E314–E321.
Albi E., Catald S., Bartoccini E., Magni M.V., Marini F., Mazzoni F. Rainaldi G., Evangelista M., and Garcia-Gil M. (2006). Nuclear sphingomyelin pathway in serum deprivation-induced apoptosis of embryonic hippocampal cells. J. Cellular Physiol. 206:189–195.
Albi E., and Viola Magni M.P. (2007). The role of intranuclear lipids. Biol Cell 96:657–667.
Albi E., Lazzarini R., and Viola Magru M. (2008). Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus. Biochem J. 410:381–389.
Bannenberg G., and Serhan C.N. (2010). Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim Biophys Acta. 1801:1260–1273.
Bazan N. G. (2005a). Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32:89–103.
Bazan N. G. (2005b). Neuroprotectin D1 (NPD1): A DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 15:159–166.
Bowers-Gentry R. C., Deems R. A., Harkewicz R., and Dennis E. A. (2006). Eicosanoid lipidomics. In: Feng L. and Prestwich G. D. (eds.), Functional Lipidomics. CRC Press-Taylor & Francis Group, Boca Raton, pp. 79–100.
Butterfield D. A., Perluigi M., and Sultana R. (2006). Oxidative stress in Alzheimer’s disease brain: New insights from redox proteomics. Eur. J. Pharmacol. 545:39–50.
Calder P.C. (2006). Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75:197–202.
Facheris M., Beretta S., and Ferrarese C. (2004). Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: Tools for diagnosis and therapy? J. Alzheimer’s Dis. 6:177–184.
Fahrenkrog B. (2006). The nuclear pore complex, nuclear transport, and apoptosis. Can. J. Physiol. Pharmacol. 84:279–286.
Fam S.S., and Morrow J.D. (2003). The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr. Med. Chem. 10: 1723–1740.
Fantini J., Garmy N., Mahfoud R., and Yahi N. (2002). Lipid rafts: structure, function and role in HIV, Alzheimer’s and prion diseases. Expert Rev Mol Med. 4:1–22.
Fantini J., and Yahi N. (2010). Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases. Expert Rev Mol Med. 12:e27.
Farooqui A. A., Horrocks L. A., and Farooqui T. (2000). Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106:1–29.
Farooqui A. A. and Horrocks L. A. (2001). Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7:232–245.
Farooqui A. A. and Horrocks L. A. (2004). Plasmalogens, platelet-activating factor, and other ether lipids. In: Nicolaou A. and Kokotos G. (eds.), Bioactive Lipids. Oily Press, Bridgwater, England, pp. 107–134.
Farooqui A.A. and Horrocks L.A. (2006). Phospholipase A2-generated lipid mediators in brain: the good, the bad, and the ugly. Neuroscientist 12:245–260.
Farooqui, A.A. and Horrocks, L.A. (2007). Glycerophospholipids in the Brain: Phospholipases A2 in Neurological Disorders, Springer, New York.
Farooqui, A.A., Horrocks, L.A., and Farooqui, T. (2007a) Interactions between neural membrane phospholipids and sphingolipids: a recipe for neural cell survival or suicide. J.Neurosci. Res. 85:1834–1850.
Farooqui, A.A., Horrocks, L.A., and Farooqui, T. (2007b) Modulation of inflammation inbrain : A matter of fat. J. Neurochem. 101:577–599.
Farooqui, A.A., Ong, W.Y., Horrocks, L.A, Chen, P., and Farooqui, T. (2007a) Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 56: 443–471.
Farooqui A.A., Ong W.Y., and Horrocks L.A. (2008). Neurochemical Aspects of Excitotoxicity, Springer, New York.
Farooqui A.A. (2009a). Hot Topics in Neural Membrane Lipidology. Springer, New York.
Farooqui A.A. (2009b). Beneficial Effects of Fish Oil on Human Brain. Springer, New York.
Farooqui A.A., Ong W.Y., Farooqui T. (2010). Lipid mediators in the nucleus: Their potential contribution to Alzheimer’s disease. Biochim Biophys Acta. 1801:906–916.
Farooqui A.A. (2010). Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases. Springer, New York.
Fonteh A.N., Harrington R.J., Huhmer A.F., Biringer R.G., Riggins J.N., and Harrington M.G. (2006). Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers. 22:39–64.
Gehrig K., Lagace T.A., and Ridgway N.D. (2009). Oxysterol activation of phosphatidylcholine synthesis involves CTP:phosphocholine cytidylyltransferase alpha translocation to the nuclear envelope. Biochem. J. 418:209–217.
German J. B., Gillies L. A., Smilowitz J. T., Zivkovic A. M., and Watkins S. M. (2007). Lipidomics and lipid profiling in metabolomics. Curr. Opin. Lipidol. 18:66–71.
Hannun Y.A., and Obeid L.M. (2008). Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell. Biol. 9:139–150.
Hogyes E., Nykas C., Kiliaan T., Farkas T., Penke B., and Luiten P.G.M. (2003) Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience. 119:999–1012.
Horrocks L.A. and Farooqui A.A. (2004).Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot. Essent. Fatty Acids. 70:361–372.
Ikeda M., Kihara A., and Igarashi Y. (2006). Lipid asymmetry of the eukaryotic plasma membrane: Functions and related enzymes. Biol. Pharm. Bull. 29:1542–1546.
Ivanova P.T., Milne S.B., Forrester J.S., and Brown H.A. (2004). LIPID arrays: new tools in the understanding of membrane dynamics and lipid signaling. Mol Interv. 4:86–96.
Jump D.B. (2004). Fatty acid regulation of gene transcription. Crit. Rev. Clin. Lab. Sci. 41:41–78.
Kang J.X., Weylandt K.H. (2008). Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell. Biochem. 49:133–143.
Kris-Etherton P.M., Taylor D.S., Yu-Poth S., Huth P., Moriarty K., Fishell V., Hargrove R.L., Zhao G., and Etherton T.D. (2000). Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 71(1 Suppl):179S–188S.
Lagace T.A., Byers D.M., Cook H.W., and Ridgway N.D. (1995). Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol. J. lipid Res. 40:109–116.
Lang P. A., Kempe D. S., Tanneur V., Eisele K., Klarl B. A., Myssina S., Jendrossek V., Ishii S., Shimizu T., Waidmann M., Hessler G., Huber S. M., Lang F., and Wieder T. (2005). Stimulation of erythrocyte ceramide formation by platelet-activating factor. J. Cell Sci. 118:1233–1243.
Latorre E., Collado M. P., Fernández I., Aragonés M. D., and Catalán R. E. (2003). Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide. Eur. J. Biochem. 270:36–46.
Ledeen R.W., and Wu G. (2008). Nuclear sphingolipids: metabolism and signaling. J Lipid Res. 49:1176–1186.
Lu Y., Hong S., Gotlinger K., and Serhan C. N. (2006). Lipid mediator informatics and proteomics in inflammation-resolution. Thescientificworldjournal 6:589–614.
Lucero H. A. and Robbins P. W. (2004). Lipid rafts-protein association and the regulation of protein activity. Arch. Biochem. Biophys. 426:208–224.
Malaplate-Armand C, Florent-Béchard S, Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier JL, Oster T, Pillot T. (2006). Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis. 23:178–189.
Martelli A.M., FolloM.Y., Evangelisti C., Fala F., Flume R., Billi A.M. (2005). Nuclear inositol lipid metabolism: more than just second messenger generation? J. Cell Biochem. 96 :285–292.
Maurer M.H. (2010). Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrom. Rev. 29:17–28.
Milne S., Ivanova P., Forrester J., and Brown H. A. (2006). Lipidomics: An analysis of cellular lipids by ESI-MS. Methods 39:92-103.
Montuschi P., Barnes P., and Roberts L.J. 2nd (2007). Insights into oxidative stress: the isoprostanes. Curr Med Chem. 14:703–717.
Naim B., Brumfeld V., Kapon R., Kiss V., Nevo R., and Reich Z (2007). Passive and facilitated transport in nuclear pore complexes is largely uncoupled. J. Biol. Chem. 282:3881–3888.
Nodai A., Machida T., Izumi S., Hamaya Y., Kohno T., Igarashi Y., Iizuka K., Minami M., and Hirafuji M. (2007). Sphingosine 1-phosphate induces cyclooxygeriase-2 via Ca2+-dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells. Life Sci. 80:1768–1776.
Olkkonen V.M., and Hynynen R. (2009). Interactions of oxysterols with membranes and proteins. Mol. Aspects Med (In press).
Park E.J., Suh M., Thomson A.B.R., Ramanujam K.S., and Clandinin M.T. (2006). Dietary gangliosides increase the content and molecular percentage of ether phospholipids containing 20:4n-6 and 22:6n-3 in weanling rat intestine. J Nutr Biochem. 17:337–344.
Palsdottir H. and Hunte C. (2004). Lipids in membrane protein structures. Biochim. Biophys. Acta Biomembr. 1666:2–18.
Perluigi M., Poon H. F., Hensley K., Pierce W. M., Klein J. B., Calabrese V., De Marco C., and Butterfield D. A. (2005). Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice - A model of familial amyotrophic lateral sclerosis. Free Radical Biol. Med. 38:960–968.
Pettus B. J., Chalfant C. E., and Hannun Y. A. (2004). Sphingolipids in inflammation: Roles and implications. Curr. Mol. Med. 4:405–418.
Phillis J.W., Horrocks L.A., and Farooqui A.A. (2006). Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res. Rev. 52:201–243.
Pyne S. (2004). Lysolipids: Sphingosine 1-phosphate and lysophosphatidic acid. In: Nicolaou A. and Kokotos G. (eds.), Bioactive Lipids. The Oily Press, Bridgwater, England, pp. 85–106.
Ridgway N.D. (1995). 25-Hydroxycholesterol stimulates sphingomyelin synthesis in Chinese hamster ovary cells. J. Lipid Res. 36:1345–1358.
Robinson B. S., Hii C. S. T., Poulos A., and Ferrante A. (1997). Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology 91:274–280.
Serhan C. N. (2005a). Mediator lipidomics. Prostaglandins Other Lipid Mediat. 77:4–14.
Serhan C. N. (2005b). Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr. Opin. Clin. Nutr. Metab. Care 8:115–121.
Serhan C. N. (2005c). Novel ω-3-derived local mediators in anti-inflammation and resolution. Pharmacol. Ther. 105:7–21.
Serhan C. N., Hong S., and Lu Y. (2006). Lipid mediator informatics-lipidomics: Novel pathways in mapping resolution. AAPS J. 8:E284–E297.
Simons K. and Ikonen E. (1997) Functional rafts in cell membranes. Nature 387:569–572.
Simopoulos A. P. (2000). Commentary on the workshop statement. Essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 63:123–124.
Simopoulos, A.P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21:495–505.
Simopoulos A. P. (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60:502–507.
Simopoulos AP. (2008). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 233:674–688.
Tillman T. S. and Cascio M. (2003). Effects of membrane lipids on ion channel structure and function. Cell Biochem. Biophys. 38:161–190.
Vanags D.M., Larsson P., Filtenmark S., Jakobsson P.J., Orrenius S., Claesson H.E., and Aguilar-Santelises M. (1997). Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells. Cell Death Differ. 4:479–86.
Weylandt K. H., Kang J. X. (2005). Rethinking lipid mediators. Lancet 366:618–620.
Wymann M.P., and Schneiter R. (2008). Lipid signalling in disease. Nat. Rev. Mol. Cell. Biol. 9:162–176.
Yahi N., Aulas A., and Fantini J. (2010). How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer’s beta amyloid peptide (Abeta1-40). PLoS One. 5:e9079.
Yamaji-Hasegawa A. and Tsujimoto M. (2006). Asymmetric distribution of phospholipids in biomembranes. Biol. Pharm. Bull. 29:1547–1553.
Yoshikawa K., Kita Y., Kishimoto K., and Shimizu T. (2006). Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure - Dual phase regulation and differential involvement of COX-1 and COX-2. J. Biol. Chem. 281:14663–14669.
Zajchowski L. D. and Robbins S. M. (2002). Lipid rafts and little caves - Compartmentalized signalling in membrane microdomains. Eur. J. Biochem. 269:737–752.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Farooqui, A.A. (2011). Perspective and Direction for Future Studies on Lipid Mediators. In: Lipid Mediators and Their Metabolism in the Brain. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9940-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9940-5_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9939-9
Online ISBN: 978-1-4419-9940-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)